![Diantha Duvall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diantha Duvall
Directeur Financier/CFO chez
CURIS, INC.
Fortune : 40 563 $ au 30/06/2026
Profil
Diantha Duvall is currently Director at BioTheryX, Inc. since 2021 and CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Former positions include Executive Director at Merck & Co., Inc. from 2009 to 2015, Global Commercial Controller at Biogen, Inc. from 2016 to 2017, Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019, and Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022.
Education includes undergraduate studies at Colby College and graduate studies including an MBA at Northeastern University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURIS, INC. 0,2 % | 07/07/2026 | 77 707 ( 0,2 % ) | 40 563 $ | 30/06/2026 |
Postes actifs de Diantha Duvall
| Sociétés | Poste | Début |
|---|---|---|
| CURIS, INC. | Directeur Financier/CFO | 05/08/2022 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Directeur/Membre du Conseil | 09/08/2021 |
Anciens postes connus de Diantha Duvall
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Directeur Financier/CFO | 01/07/2022 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 01/01/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2017 |
| MERCK & CO., INC. | Directeur/Membre du Conseil | 01/01/2015 |
Formation de Diantha Duvall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
